Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Gervasoni, Rina Muñoz, G. Wengler, A. Rizzi, A. Zaniboni, O. Parolini (2008)
Molecular signature detection of circulating tumor cells using a panel of selected genes.Cancer letters, 263 2
M. Mohagheghi, A. Mosavi-Jarrahi, R. Malekzadeh, M. Parkin (2009)
Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998-2001.Archives of Iranian medicine, 12 1
G. Tzimagiorgis, Evangelia Michailidou, A. Kritis, A. Markopoulos, S. Kouidou (2011)
Recovering circulating extracellular or cell-free RNA from bodily fluids.Cancer epidemiology, 35 6
Robert Smith, V. Cokkinides, A. Eschenbach, B. Levin, C. Cohen, C. Runowicz, S. Sener, D. Saslow, H. Eyre (2002)
American Cancer Society Guidelines for the Early Detection of CancerCA: A Cancer Journal for Clinicians, 52
Seyed Mousavi, Mohammad Mohaghegghi, Alireza Mousavi-Jerrahi, A. Nahvijou, Z. Seddighi (2006)
Burden of breast cancer in Iran: a study of the Tehran population based cancer registry.Asian Pacific journal of cancer prevention : APJCP, 7 4
D. Parkin, F. Bray, J. Ferlay, P. Pisani (2005)
Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 55
Seyed Mousavi, M. Gouya, R. Ramazani, M. Davanlou, N. Hajsadeghi, Z. Seddighi (2009)
Cancer incidence and mortality in Iran.Annals of oncology : official journal of the European Society for Medical Oncology, 20 3
A. Stathopoulou, I. Vlachonikolis, D. Mavroudis, M. Perraki, C. Kouroussis, S. Apostolaki, N. Malamos, S. Kakolyris, A. Kotsakis, N. Xenidis, D. Reppa, V. Georgoulias (2002)
Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 16
A. Jemal, F. Bray, Melissa Center, J. Ferlay, Elizabeth Ward, David Forman (2011)
Global Cancer Statistics
J. Gustafsson, M. Warner (2000)
Estrogen receptor β in the breast: role in estrogen responsiveness and development of breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 74
C. Alix-Panabières, J. Vendrell, M. Slijper, O. Pellé, É. Barbotte, G. Mercier, W. Jacot, M. Fabbro, K. Pantel (2009)
Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancerBreast Cancer Research : BCR, 11
B. Zehentner, D. Carter (2004)
Mammaglobin: a candidate diagnostic marker for breast cancer.Clinical biochemistry, 37 4
D. Hayes, T. Walker, B. Singh, E. Vitetta, J. Uhr, S. Gross, C. Rao, G. Doyle, L. Terstappen (2002)
Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer.International journal of oncology, 21 5
M. Reinholz, Andrea Nibbe, Leslie Jonart, K. Kitzmann, V. Suman, J. Ingle, R. Houghton, B. Zehentner, P. Roche, W. Lingle (2005)
Evaluation of a Panel of Tumor Markers for Molecular Detection of Circulating Cancer Cells in Women with Suspected Breast CancerClinical Cancer Research, 11
Y. Niv (2008)
MUC1 and colorectal cancer pathophysiology considerations.World journal of gastroenterology, 14 14
who.int [homepage on the internet]. World Health Organization Regional Office for the Eastern Mediterranean
M. Dowsett, A. Dunbier (2008)
Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast CancerClinical Cancer Research, 14
M. Duffy (2006)
Serum tumor markers in breast cancer: are they of clinical value?Clinical chemistry, 52 3
S. Tovey, C. Witton, J. Bartlett, P. Stanton, J. Reeves, T. Cooke (2004)
Outcome and human epidermal growth factor receptor (HER) 1–4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labellingBreast Cancer Research, 6
A. Silva, M. Tomé, A. Correia, J. Passos-Coelho (2002)
Human mammaglobin RT-PCR assay for detection of occult breast cancer cells in hematopoietic products.Annals of oncology : official journal of the European Society for Medical Oncology, 13 3
A. Jemal, F. Bray, Melissa Center, J. Ferlay, Elizabeth Ward, D. Forman (2011)
Global cancer statisticsCA: A Cancer Journal for Clinicians, 61
(2007)
lecular detection of cytokeratin - 19 - positive cells in the peripheral blood of patients with operable breast cancer : evaluation of their prognostic significance
N. Dubrawsky (1989)
Cancer statisticsCA: A Cancer Journal for Clinicians, 39
M. Santisteban, C. Reynolds, Emily Fritcher, M. Frost, R. Vierkant, S. Anderson, A. Degnim, D. Visscher, V. Pankratz, L. Hartmann (2010)
Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasiaBreast Cancer Research and Treatment, 121
J. Ferlay, P. Autier, M. Boniol, M. Heanue, M. Colombet, P. Boyle (2006)
Estimates of the cancer incidence and mortality in Europe in 2006.Annals of oncology : official journal of the European Society for Medical Oncology, 18 3
Robert Smith, V. Cokkinides, H. Eyre (2003)
American Cancer Society Guidelines for the Early Detection of Cancer, 2003CA: A Cancer Journal for Clinicians, 53
K. Carraway, V. Ramsauer, C. Carraway (2005)
Glycoprotein contributions to mammary gland and mammary tumor structure and function: Roles of adherens junctions, ErbBs and membrane MUCsJournal of Cellular Biochemistry, 96
R Etzioni, N Urban, S Ramsey (2003)
The case for early detectionNat Rev Cancer, 3
V. Vlassov, P. Laktionov, E. Rykova (2010)
Circulating nucleic acids as a potential source for cancer biomarkers.Current molecular medicine, 10 2
P. Paterlini-Bréchot, N. Benali (2007)
Circulating tumor cells (CTC) detection: clinical impact and future directions.Cancer letters, 253 2
A. Jemal, R. Siegel, Elizabeth Ward, Taylor Murray, Jiaquan Xu, M. Thun (2007)
Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 57
Yinghua Chen, O. Olopade (2008)
MYC in breast tumor progressionExpert Review of Anticancer Therapy, 8
A. Gilbey, David Burnett, Robert Coleman, I. Holen (2004)
The detection of circulating breast cancer cells in bloodJournal of Clinical Pathology, 57
M. Lacroix (2006)
Significance, detection and markers of disseminated breast cancer cells.Endocrine-related cancer, 13 4
Ruth Etzioni, N. Urban, S. Ramsey, M. McIntosh, S. Schwartz, B. Reid, J. Radich, G. Anderson, L. Hartwell (2003)
Early detection: The case for early detectionNature Reviews Cancer, 3
R. Houghton, D. Dillon, D. Molesh, B. Zehentner, Jiangchun Xu, John Jiang, Cheryl Schmidt, Anthony Frudakis, E. Repasky, Aristides Filho, Marcos Nolasco, R. Badaró, Xinqun Zhang, P. Roche, D. Persing, S. Reed (2001)
Transcriptional Complementarity in Breast Cancer: Application to Detection of Circulating Tumor CellsMolecular Diagnosis, 6
M. Conzelmann, U. Linnemann, M. Berger (2005)
Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use?International Journal of Colorectal Disease, 20
L. Harris, H. Fritsche, R. Mennel, L. Norton, P. Ravdin, S. Taube, M. Somerfield, D. Hayes, R. Bast (2007)
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 33
M. Mitas, K. Mikhitarian, C. Walters, P. Baron, B. Elliott, T. Brothers, Jay Robison, J. Metcalf, Y. Palesch, Zhen Zhang, W. Gillanders, D. Cole (2001)
Quantitative real‐time RT‐PCR detection of breast cancer micrometastasis using a multigene marker panelInternational Journal of Cancer, 93
L. Xi, Daniel Nicastri, T. El-Hefnawy, S. Hughes, J. Luketich, T. Godfrey (2007)
Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers.Clinical chemistry, 53 7
Chung-Chi Chen, M. Hou, Jaw-Yuan Wang, Tsai-Wang Chang, D. Lai, Yi-Fang Chen, Sung-Yu Hung, Shiu‐Ru Lin (2006)
Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis.Cancer letters, 240 2
T. Jotsuka, Y. Okumura, S. Nakano, H. Nitta, Takashi Sato, M. Miyachi, K. Suzumura, Jun-ichi Yamashita (2004)
Persistent evidence of circulating tumor cells detected by means of RT-PCR for CEA mRNA predicts early relapse: a prospective study in node-negative breast cancer.Surgery, 135 4
(2003)
American Cancer Society guidelines for the early detection of cancer . American Cancer Society
A biomarker is a quantifiable laboratory measure of a disease specific biologically relevant molecule that can act as an indicator of a current or future disease state. The purpose of this study is to detect the expression of RNA biomarkers using Cytokeratin 19 (CK-19), Mammaglobin (MAM), Carcinoembryonic antigen (CEA), Mucin (MUC), C-Myc, erb-B2, a proliferation marker (Ki-67), Epidermal growth factor receptor (Her2/neu) and Estrogen receptor (ER) in Iranian women who were diagnosed with breast cancer. In this study, 90 samples; 60 cancer patients and 30 healthy controls were considered. 73.4 % patients were in stage I/II and 26.6 % were in stage III/IV. Patients were selected prior to the administration of any adjuvant systemic therapy. Total RNA extraction was obtained from peripheral blood of each patient and healthy control. Reverse transcription polymerase chain reaction (RT-PCR) method was used for detection of mRNA of the selected biomarkers of circulating breast cancer cells in blood. Molecular characterization is assessed as a method for early detection of breast cancer. For this purpose, eleven specific primers were selected and RT-PCR was used. The data of RT-PCR revealed that expression of MUC1, CK19, CEA, MAM, erbB-2, Ki67 and C-Myc biomarkers were significantly different between breast cancer patients and healthy controls. On the other hand, ERα, ERβ and Her2 markers were not significantly different between the two mentioned groups. Biomarkers detection of breast cancer patients could be assessed as a diagnostic factor and its potential for conveying as a prognostic factor require further studies, with a larger number of patients.
Cancer Microenvironment – Springer Journals
Published: Jul 25, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.